58106-55-1

Basic information

• Product Name: 2,4-dihydroxy-3-bromo-6-methyl-benzoic acid methyl ester
• Synonyms: 2,4-dihydroxy-3-bromo-6-methyl-benzoic acid methyl ester
• CAS NO: 58106-55-1
• Molecular Weight: 261.072
• Mol File: 58106-55-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2,4-dihydroxy-3-bromo-6-methyl-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-dihydroxy-3-bromo-6-methyl-benzoic acid methyl ester(58106-55-1)
• EPA Substance Registry System: 2,4-dihydroxy-3-bromo-6-methyl-benzoic acid methyl ester(58106-55-1)

Safety Data

• Hazardous Substances Data: 58106-55-1(Hazardous Substances Data)

Upstream product

• 105450-80-4 1,3-Dibromo-2-hydroxy-6-methyl-4-oxo-cyclohex-2-enecarboxylic acid methyl ester 
• 39493-62-4 2-oxo-4-hydroxy-6-methyl-cyclohex-3-ene carboxylic acid methyl ester 

Downstream Products

• 86832-77-1 dl-5-chloro-2,4-dihydroxy-6-methyl-3-[(2E,6E)-3-methyl-7-(3,3-dimethyl-4-oxo-2-oxacyclopentyl)-2,6-octadienyl]benzaldehyde 
• 109625-60-7 3-chloro-2-methyl-5-<(E,E)-3-methyl-7-(tetrahydro-5,5-dimethyl-4-oxofuran-2-yl)octa-2,6-dienyl>-4,6-bis<2-(trimethylsilyl)ethoxymethoxy>benzaldehyde 
• 113899-02-8 methyl 3-chloro-5-<(E,E)-7-(2,5-dihydro-5,5-dimethyl-4-pivaloyloxyfuran-2-yl)-3-methylocta-2,6-dienyl>-2-methyl-4,6-bis<2-(trimethylsilyl)ethoxymethoxy>benzoate 
• 105427-90-5 methyl 2,4-bis[2-(trimethylsilyl)ethoxymethoxy]-3-bromo-5-chloro-6-methylbenzoate 
• 34132-35-9 2,4-dimethoxy-3-bromo-6-methyl-benzoic acid methyl ester 
• 43043-16-9 (S)-colletochlorin A 

Relevant articles and documents

Diarylvinylene similar structure compound and its preparation method and application

The invention discloses a group of diarylethene structure similar compounds as well as a preparation method and application thereof. The provided compounds have a structure of a general formula I. Moreover, the invention further provides medicinal compositions containing the compounds serving as active ingredients. Researches discover that the compounds have pharmacological activities of resisting influenza viruses, Coxsackie B3 viruses, AIDS viruses, hepatitis B viruses, hepatitis C viruses and the like. Therefore, the invention further provides the application of the compounds and the medicinal compositions containing the compounds serving as active ingredients in preparation of anti-virus medicaments. The invention lays a foundation for deeply researching and developing the application of the compounds as clinical medicaments. The general formula I is as shown in the specification.

CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE

Provided are cajanine structure analogous compounds, synthesis method and pharmacological effects thereof, the compounds of the present invention having the structure as represented by general formulas I, II, III, IV and V. Also provided are pharmaceutical compositions containing the compounds as active ingredient, and uses thereof; the compounds of the present invention having the pharmacological activities such as anti-virus, anti-virus-infection, nerve protection, anti-metabolic-diseases and the like. Also provided is a chemical total synthesis preparation method of the natural products cajanine, cajanine A and cajanine C. The present invention lays a foundation for the in-depth study and development of the compounds as clinical drugs in the future.